Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Lacto Japan, 17% Decrease in Ordinary Profit for The Current Fiscal Year
3139 Lacto Japan Co.,Ltd. 【J-GAAP】
Earnings ReportLacto Japan Co.,Ltd. <3139> [TSE Prime] announced its financial results after the market closed on January 14th (15:30). The consolidated ordinary profit for the fiscal year ended November 2025 expanded to 34.2% from the previous period to 5.79 billion yen. However, for the fiscal year ending November 2026, the consolidated ordinary profit is expected to decrease by 17.2% from the previous period to 4.80 billion yen.
In the most recent three-month period, from September to November (4Q), the consolidated ordinary profit grew 5.7% from the same period last year, reaching 0.88 billion yen. The operating profit margin remained almost flat, changing from 2.3% in the same period last year to 2.5%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Nov, 2023 | 158,328 | 3,184 | 2,847 | 2,048 | 206.5 | 48 | Jan 12, 2024 | J-GAAP |
| Nov, 2024 | 170,907 | 4,455 | 4,320 | 3,146 | 315.8 | 80 | Jan 14, 2025 | J-GAAP |
| Nov, 2025 | 182,816 | 5,947 | 5,796 | 4,317 | 433.2 | 132 | Jan 14, 2026 | J-GAAP |
| YoY | +7.0% | +33.5% | +34.2% | +37.2% | +37.2% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Nov, 2025 Guidance | 188,000 | ー | 6,000 | 4,350 | 436.3 | 132 | Jul 9, 2025 | J-GAAP |
| Nov, 2025 Results | 182,816 | 5,947 | 5,796 | 4,317 | 433.2 | 132 | Jan 14, 2026 | J-GAAP |
| Revision Rate | -2.8% | - | -3.4% | -0.8% | -0.7% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec - May, 2024 | 95,293 | 3,571 | 3,832 | 2,797 | 280.8 | 50 | Jul 14, 2025 | J-GAAP |
| Dec - May, 2025 Guidance | 95,500 | ー | 2,250 | 1,620 | 162.5 | 66 | Jan 14, 2026 | J-GAAP |
| YoY | +0.2% | - | -41.3% | -42.1% | -42.1% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Nov, 2024 | 170,907 | 4,455 | 4,320 | 3,146 | 315.8 | 80 | Jan 14, 2025 | J-GAAP |
| Nov, 2025 | 182,816 | 5,947 | 5,796 | 4,317 | 433.2 | 132 | Jan 14, 2026 | J-GAAP |
| Nov, 2026 Guidance | 193,000 | ー | 4,800 | 3,450 | 346.0 | 132 | Jan 14, 2026 | J-GAAP |
| YoY | +5.6% | - | -17.2% | -20.1% | -20.1% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Sep - Nov, 2024 | 42,729 | 993 | 841 | 602 | 60.4 | 2.3 | Jan 14, 2025 | J-GAAP |
| Dec - Feb, 2024 | 45,984 | 1,672 | 1,598 | 1,202 | 120.8 | 3.6 | Apr 14, 2025 | J-GAAP |
| Mar - May, 2025 | 49,309 | 1,899 | 2,234 | 1,595 | 160.1 | 3.9 | Jul 14, 2025 | J-GAAP |
| Jun - Aug, 2025 | 42,138 | 1,241 | 1,075 | 762 | 76.5 | 2.9 | Oct 14, 2025 | J-GAAP |
| Sep - Nov, 2025 | 45,385 | 1,135 | 889 | 758 | 76.1 | 2.5 | Jan 14, 2026 | J-GAAP |
| YoY | +6.2% | +14.3% | +5.7% | +25.9% | +25.8% |
Related Articles
Kitanotatsujin, Mar-Nov (Cumulative 3Q) Ordinary Profit Decreases by 48%, Sep-Nov Ordinary Profit Decreases by 56%
AFC-HD AMS Life Science, Sep-Nov (1Q) Ordinary Profit Increases by 5%
Kewpie, 7% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, Dividend Raised by 1 Yen
CCReB Advisors, Sep-Nov (1Q) Ordinary Profit Decreases by 31%
STUDIO ALICE, Mar-Nov (Cumulative 3Q) Ordinary Profit Decreases by 22%, Sep-Nov Ordinary Profit Decreases by 21%
SAIZERIYA, Sep-Nov (1Q) Ordinary Profit Increases by 17%
LOGOS HOLDINGS, First Half Ordinary Profit Loss Narrows, Sep-Nov Ordinary Profit Increases by 3.2 times
Asterisk, Sep-Nov (1Q) Ordinary Profit Loss Narrows
SFP Holdings, Mar-Nov (Cumulative 3Q) Ordinary Profit Decreases by 27%, Sep-Nov Ordinary Profit Decreases by 60%
KAWAKAMI PAINT, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 2.5 times Increase in The Current Fiscal Year, Dividend Raised by 1 Yen